Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease.

Berger, W E; Nadel, J A

Berger, W E; Nadel, J A.

Affiliation

Berger WE; Allergy and Asthma Associates of Southern California, 27800 Medical Asthma Associates, Suite 244, Mission Viejo, CA 92691, USA. weberger@uci.edu

Respir Med ; 102(2): 173-88, 2008 Feb.

Article in En | MEDLINE | ID: mdl-18023995

Subject(s)

Adrenergic beta-Agonists/therapeutic use; Bronchodilator Agents/therapeutic use; Ethanolamines/therapeutic use; Pulmonary Disease, Chronic Obstructive/drug therapy; Administration, Inhalation; Aged; Bronchodilator Agents/adverse effects; Dose-Response Relationship, Drug; Ethanolamines/adverse effects; Formoterol Fumarate; Humans; Middle Aged; Practice Guidelines as Topic; Randomized Controlled Trials as Topic

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Adrenergic beta-Agonists / Pulmonary Disease, Chronic Obstructive / Ethanolamines Type of study: Clinical_trials / Guideline Limits: Aged / Humans / Middle aged Language: En Journal: Respir Med Year: 2008 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links